Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-31 @ 7:30 AM
Study NCT ID:
NCT01515969
Status:
TERMINATED
Last Update Posted:
2016-07-12
First Post:
2011-12-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Heather Wakelee
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-16
First Submit QC Date:
None
Study First Post Date:
2012-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-11
Last Update Post Date:
2016-07-12
Last Update Post Date Type:
ESTIMATED